DAIC

APRIL 22, 2024

RCE Technologies, Inc. RCE) is an innovative artificial intelligence (AI) based medical technology company dedicated to early heart attack detection. RCE) is an innovative artificial intelligence (AI) based medical technology company dedicated to early heart attack detection. Featured in an ACC.24 Featured in an ACC.24

Technology 105

Technology Biomarkers Heart Attack Heart attacks 105

DAIC

MARCH 6, 2024

a biomarker-guided predictive care company, has presented data showing its FDA-cleared, non-invasive, biomarker-based technology for remote heart failure monitoring detected twice as many heart failure events as compared to the weight-based standard of care. Bodyport Inc., Image courtesy: Bodyport Inc.

Heart Failure 128

Heart Failure Technology Biomarkers Hospital 128

DAIC

DECEMBER 22, 2023

a medical technology company focused on transforming cardiac care through the power of personalized insights, announced significant developments for the use of artificial intelligence (AI) applied to its proprietary vectorelectrocardiography (VECG) technology, including the addition of new leadership and advisory roles.

Technology 105

Technology Electrocardiogram Heart Rhythm Biomarkers 105

Cardiometabolic Health Congress

JULY 25, 2024

A jam-packed, expertly curated agenda will highlight the latest and most impactful advancements in cardiorenal metabolic medicine and protocols for future-focused, whole-patient care.

Education 100

Education Innovation Risk Factors Obesity 100

GEMMS

MAY 22, 2024

Advancements in medical technology have revolutionized the diagnosis and treatment of heart diseases, which pose critical chronic conditions that, if left unattended, can have fatal consequences. Startups are developing image analytics solutions using deep learning technologies to improve patient outcomes.

Heart Disease 52

Heart Disease Blood Pressure Technology Innovation 52

DAIC

MAY 17, 2024

milla1cf Fri, 05/17/2024 - 18:54 May 17, 2024 — Royal Philips , a global leader in health technology, is presenting new retrospective study results demonstrating the clinical and economic benefits of Philips’ AI-powered cardiac care solutions at the Heart Rhythm Annual Meeting in Boston (May 16-19).

Heart Rhythm 52

Heart Rhythm Technology Arrhythmia Outcomes 52

CardiacWire

DECEMBER 3, 2023

Jimenez: Accucardia is an ECG-led diagnostics company, leveraging ECG as a broad biomarker for cardiology and beyond. That will allow physicians, clinicians, and technicians to dedicate more time to the most necessary areas, like direct patient care or more complicated analysis which requires clinical intuition built from years of experience.

Arrhythmia 52

Arrhythmia Atrial Flutter Reimbursement Atrial Fibrillation 52